Home
About
FAQ
History (13)
Incidental Findings on Lung Cancer Screening: Significance and Management.
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.
Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
BEARR: Batch Extraction and Analysis of cis-Regulatory Regions.
Dmp1a inhibits HER2/neu-induced mammary tumorigenesis.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dmp1a inhibits HER2/neu-induced mammary tumorigenesis.
Fry EA, Taneja P, Maglic D, Zhu S, Sui G, Inoue K. Dmp1a inhibits HER2/neu-induced mammary tumorigenesis. PLoS One. 2013; 8(10):e77870.
View in:
PubMed
subject areas
Animals
Blotting, Western
Cell Transformation, Neoplastic
Extracellular Matrix Proteins
Female
Gene Dosage
Humans
Immunoenzyme Techniques
Mammary Neoplasms, Experimental
Mice
Mice, Transgenic
Receptor, erbB-2
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Survival Rate